Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol)

Journal of Medicinal Chemistry

Volumn 41, Issue 19, 1998, Pages 3715-3726

  Kingston, David G I ^a   Chaudhary, Ashok G ^a   Chordia, Mahendra D ^a   Gharpure, Milind ^a   Gunatilaka, A A Leslie ^a   Higgs, Paul I ^a   Rimoldi, John M ^a   Samala, Lakshman ^a   Jagtap, Prakash G ^a   Giannakakou, Paraskevi ^b   Jiang, Yuan Q ^c   Lin, Chii M ^c   Hamel, Ernest ^c   Long, Byron H ^d   Fairchild, Craig R ^d   Johnston, Kathy A ^d  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; OVARY CANCER; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOPOLYMERS; CATALYSIS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PACLITAXEL; POLYETHYLENE GLYCOLS; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN; TUMOR CELLS, CULTURED;

EID: 15144350837     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980229d     Document Type: Article

References (55)

1. Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. Plant Antitumor Agents. VI. The Isolation and Structure of Taxol, a Novel Antileukemic and Antitumor Agent from Taxus brevifolia. J. Am. Chem. Soc. 1971, 93, 2325-2327.
2. (a) Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of Microtubule Assembly in Vitro by Taxol. Nature 1979, 277, 665-667.
3. (b) Manfredi, J. J.; Horwitz, S. B. Taxol: An Antimitotic Agent with a New Mechanism of Action. Pharmacol. Ther. 1984, 25, 83-125.
4. (a) Arbuck, S. G.; Blaylock, B. A. Taxol: Clinical Results and Current Issues in Development. In Taxol: Science and Applications; Suffness, M., Ed.; CRC Press: Boca Raton, FL, 1995; pp 379-415.
5. (b) Holmes, F. A.; Kudelka, A. P.; Kavanagh, J. J.; Huber, M. H.; Ajani, J. A.; Valero, V. Current Status of Clinical Trials with Paclitaxel and Docetaxel. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; ACS Symposium Series 583; American Chemical Society: Washington, DC, 1994; pp 31-57.
6. Donehower, R. C.; Rowinsky, E. K. An Overview of Experience with Taxol (Paclitaxel) in the U.S.A. Cancer. Treat. Rev. 1993, 19 (Suppl.), 63-78.
7. Rowinsky, E. K.; Donehower, R. C. Paclitaxel (Taxol). N. Engl. J. Med. 1995, 1004-1014.
8. (a) Chen, S.-H.; Farina, V. Paclitaxel Structure-Activity Relationships and Core Skeletal Rearrangements. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen, T. T., Ojima, I., Vyas, D. M., Eds.; ACS Symposium Series 583; American Chemical Society: Washington, DC, 1994; pp 247-261.
9. (b) Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. The Medicinal Chemistry of Taxol. In Taxol: Science and Applications; Suffness, M., Ed.; CRC Press: Boca Raton, FL, 1995; pp 317-375.
10. Kingston, D. G. I. The Chemistry of Taxol. Pharmacol. Ther. 1991, 52, 1-34.
11. Kingston, D. G. I. Taxol: the Chemistry and Structure-Activity Relationships of a Novel Anticancer Agent. Trends Biotechnol. 1994, 12, 222-227.
12. (e) Kingston, D. G. I. Recent Advances in the Chemistry and Structure-Activity Relationships of Paclitaxel. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I., Chen. T. T., Ojima, I., Vyas, D. M., Eds.; ACS Symposium Series 583; American Chemical Society: Washington, DC, 1994; pp 203-216.
13. (f) Kingston, D. G. I. History and Chemistry. In Paclitaxel in Cancer Treatment; McGuire, W. P., Rowinsky, E. K., Eds.; Marcel Dekker: New York, Basel, Hong Kong, 1995; Vol. 8, pp 1-33.
14. (g) Nicolaou, K. C.; Dai, W.-M.; Guy, R. K. Chemistry and Biology of Taxol. Angew. Chem., Int. Ed. Engl. 1994, 33, 15-44.
15. Samaranayake, G.; Magri, N. F.; Jitrangsri, C.; Kingston, D. G. I. Modified Taxols. 5. Reaction of Taxol with Electrophilic Reagents and Preparation of a Rearranged Taxol Derivative with Tubulin Assembly Activity. J. Org. Chem. 1991, 56, 5114-5119.
16. Neidigh, K. A.; Gharpure, M. M.; Rimoldi, J. M.; Kingston, D. G. I.; Jiang, Y. Q.; Hamel, E. Synthesis and Biological Evaluation of 4-Deacetylpaclitaxel. Tetrahedron Lett. 1994, 35, 6839-6842.
17. (b) Chordia, M. D.; Chaudhary, A. G.; Kingston, D. G. I.; Jiang, Y. Q.; Hamel, E. Synthesis and Biological Evaluation of 4-Deacetoxypaclitaxel. Tetrahedron Lett. 1994, 35, 6843-6846.
18. Datta, A.; Jayasinghe, L. R.; Georg, G. I. 4-Deacetyltaxol and 10-Acetyl-4-deacetyltaxotere: Synthesis and Biological Evaluation. J. Med. Chem. 1994, 37, 4258-4260.
19. (a) Chen, S.-H.; Kadow, J. F.; Farina, V.; Fairchild, C. R.; Johnston, K. A. First Syntheses of Novel Paclitaxel (Taxol) Analogues Modified at the C4-Position. J. Org. Chem. 1994, 59, 6156-6158.
20. (b) Chen, S.-H.; Fairchild, C.; Long, B. H. Synthesis and Biological Evaluation of Novel C-4 Aziridine Bearing Paclitaxel (Taxol) Analogues. J. Med. Chem. 1995, 38, 2263-2267.
21. Chen, S.-H.; Wei, J.-M.; Long, B. H.; Fairchild, C. A.; Carboni, J.; Mamber, S. W.; Rose, W. C.; Johnston, K.; Casazza, A. M.; Kadow, J. F.; Farina, V.; Vyas, D.; Doyle, T. W. Novel C-4 Paclitaxel (Taxol) Analogues: Potent Antitumor Agents. Bioorg. Med. Chem. Lett. 1995, 5, 2741-2746.
22. Georg, G. I.; Ali, S. M.; Boge, T. C.; Data, A.; Falborg, L.; Himes, R. H. Selective C-2 and C-4 Deacylation and Acylation of Taxol: The First Synthesis of a C-4 Substituted Taxol Analogue. Tetrahedron Lett. 1994, 35, 8931-8934.
23. Chaudhary, A. G.; Gharpure, M. M.; Rimoldi, J. M.; Chordia, M. D.; Gunatilaka, A. A. L.; Kingston, D. G. I.; Grover, S.; Lin, C. M.; Hamel, E. Unexpectedly Facile Hydrolysis of the 2-Benzoate Group of Taxol and Synthesis of Analogues with Increased Activities. J. Am. Chem. Soc. 1994, 116, 4097-4098.
24. (a) Georg, G. L; Harriman, G. C. B.; Ali, S. M.; Datta, A.; Hepperle, M.; Himes, R. H. Synthesis of 2-O-Heteroaroyl Taxanes: Evaluation of Microtubule Assembly Promotion and Cytotoxicity. Bioorg. Med. Chem. Lett. 1995, 5, 115-118.
25. (b) Georg, G. L; Ali, S. M.; Boge, T. C.; Datta, A.; Falborg, L.; Park, H.; Mejillano, M.; Himes, R. H. Synthesis of Biologically Active 2-Benzoyl Paclitaxel Analogues. Bioorg. Med. Chem. Lett. 1995, 5, 259-264.
26. Nicolaou, K. C.; Couladouros, E. A.; Nantermet, P. G.; Renaud, J.; Guy, R. K.; Wrasidlo, W. Synthesis of C-2 Taxol Analogues, Angew. Chem., Int. Ed. Engl. 1994, 33, 1581-1583.
27. Nicolaou, K. C.; Renaud, J.; Nantermet, P. G.; Couladouros, E. A.; Guy, R. K.; Wrasidlo, W. Chemical Synthesis and Biological Evaluation of C-2 Taxoids. J. Am. Chem. Soc. 1995, 117, 2409-2420.
28. (e) Chen, S.; Farina, V.; Wei, J.; Long, B.; Fairchild, C.; Mamber, S. W.; Kadow, J. F.; Vyas, D.; Doyle, T. W. Structure-Activity Relationships of Taxol: Synthesis and Biological Evaluation of C-2 Taxol Analogues. Bioorg. Med. Chem. Lett. 1994, 4, 479-482.
29. (f) Grover, S.; Rimoldi, J. M.; Molinero, A. A.; Chaudhary, A. G.; Kingston, D. G. I.; Hamel, E. Differential Effects of Paclitaxel (Taxol) Analogues Modified at Positions C-2, C-7, and C-3′ on Tubulin Polymerization and Polymer Stabilization: Identification of a Hyperactive Paclitaxel Derivative. Biochemistry 1995, 34, 3927-3934.
30. (g) Ojima, I.; Duclos, O.; Zucco, M.; Lavelle, F. Synthesis and Structure-Activity Relationships of New Antitumor Taxoids. Effects of Cyclohexyl Substitution at the C-3′ and/or C-2 of Taxotere (Docetaxel). J. Med. Chem. 1994, 37, 2602-2608.
31. (h) Holton, R. A.; Kim, S. Process for the Preparation of Baccatin III Analogues Bearing New C-2 and C-4 Functional Groups. U.S. Patent 5,-399, 726, March 21, 1995.
32. Ojima, I.; Kuduk, S. D.; Pera, P.; Veith, J. M.; Bernacki, R. J. Syntheses and Structure-Activity Relationships of Nonaromatic Taxoids: Effects of Alkyl and Alkenyl Ester Groups on Cytotoxicity. J. Med. Chem. 1997, 40, 279-285.
33. (a) Vander Velde, D. G.; Georg, G. I.; Grunewald, G. L.; Gunn, C. W.; Mitscher, L. A. "Hydrophobie Collapse" of Taxol and Taxotere Solution Conformations in Mixtures of Water and Organic Solvent. J. Am. Chem. Soc. 1993, 115, 11650-11651.
34. (b) Williams, H. J.; Scott, A. I.; Dieden, R. A.; Swindell, C. S.; Chirlian, L. E.; Francl, M. M.; Heerding, J. M.; Krauss, N. E. NMR and Molecular Modeling Study of Active and Inactive Taxol Analogues in Aqueous and Nonaqueous Solution. Can. J. Chem. 1994, 72, 252-260.
35. Ojima, I.; Kuduk, S. D.; Chakravarty, S.; Ourevitch, M.; Bégué, J.-P. A Novel Approach to the Study of Solution Structures and Dynamic Behavior of Paclitaxel and Docetaxel Using Fluorine-Containing Analogues as Probes. J. Am. Chem. Soc. 1997, 119, 5519-5527.
36. Miller, R. W.; Powell, R. G.; Smith, C. R., Jr.; Arnold, E.; Clardy, J. Antileukemic Alkaloids from Taxus wallichiana Zucc. J. Org. Chem. 1981, 46, 1469-1474.
37. Samaranayake, G.; Neidigh, K. A.; Kingston, D. G. I. Modified Taxols. 8. Deacylation and Reacylation of Baccatin III. J. Nat. Prod. 1993, 56, 884-898.
38. Flynn, D. L.; Zelle, R. E.; Grieco, P. A. A Mild Two-Step Method for the Hydrolysis/Methanolysis of Secondary Amides and Lactams. J. Org. Chem. 1983, 48, 2424-2426.
39. Farina, V.; Huang, S. The Chemistry of Taxanes: Unexpected Rearrangement of Baccatin III During Chemoselective Debenzoylation with Bu3SnOMe/LiCl. Tetrahedron Lett. 1992, 33, 3979-3982.
40. (a) Denis, J.-N.; Greene, A. E.; Guenard, D.; Gueritte-Voegelein, F.; Mangatal, L.; Potier, P. A Highly Efficient, Practical Approach, to Natural Taxol. J. Am. Chem. Soc. 1988, 110, 5917-5919.
41. (b) Ojima, I.; Habus, I.; Zhao, M.; Zucco, M.; Park, Y. H.; Sun, C. M.; Brigaud, T. New and efficient approaches to the semisynthesis of taxol and its C-13 side chain analogues by means of β-lactam synthon method. Tetrahedron 1992, 48, 6985-7012.
42. Holton, R. A.; Biediger, R. J.; Boatman, P. D. Semisynthesis of Taxol and Taxotere. In Taxol: Science and Applications; Suffness, M., Ed.; CRC Press: Boca Raton, FL, 1995; pp 97-121.
43. Lin, C. M.; Jiang, Y. Q.; Chaudhary, A. G.; Rimoldi, J. M.; Kingston, D. G. I.; Hamel, E. A Convenient Tubulin-Based Quantitative Assay for Paclitaxel (Taxol) Derivatives More Effective in Inducing Assembly than the Parent Compound. Cancer Chemother. Pharmacol. 1996, 38, 136-140.
44. 50 is enclosed in quotation marks at its first appearance because taxoids actually enhance tubulin polymerization. In the assay used here, the drug concentration required to reduce the protein in the supernatant by 50% was determined, since the drug-induced polymer is removed from the reaction mixture by centrifugation.
45. Hamel, E.; del Campo, A. A.; Lowe, M. C.; Lin, C. M. Interactions of Taxol, Microtubule-Associated Proteins, and Guanine Nucleotides in Tubulin Polymerization. J. Biol. Chem. 1981, 256, 11887-11894.
46. Rimoldi, J. M.; Kingston, D. G. L; Chaudhary, A. K.; Samaranayake, G.; Grover, S.; Hamel, E. Modified Taxols, 9. Synthesis and Biological Evaluation of 7-Substituted Photoaffinity Analogues of Taxol. J. Nat. Prod. 1993, 56, 1313-1330.
47. Behrens, B. C.; Hamilton, T. C.; Masuda, H.; Grotzinger, K. R.; Whang-Peng, J.; Louie, K. G.; Knutsen, T.; McKoy, W. M.; Young, R. C.; Ozols, R. F. Characterization of a cis-Diaminedichloroplatinum(II)-Resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues. Cancer Res. 1987, 47, 414-418.
48. Giannakakou, P.; Sackett, D. L.; Kang, Y.-K.; Zhan, Z.; Buters, J. T. M.; Fojo, T.; Poruchynsky, M. S. Paclitaxel resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel driven polymerization. J. Biol. Chem. 1997, 272, 17118-17125.
49. Hansch, C.; Leo, A.; Unger, S. H.; Kim, K. H.; Nikaitani, D.; Lien, E. J. "Aromatic" Substituent Constants for Structure-Activity Correlations. J. Med. Chem. 1973, 16, 1207-1216.
50. 50 values greater than 20% are considered significant.
51. Hamel, E.; Lin, C. M. Separation of Active Tubulin and Microtubule-Associated Proteins by Ultracentrifugation and Isolation of a Component Causing the Formation of Microtubule Bundles. Biochemistry 1984, 23, 4173-4184.
52. ter Haar, E.; Kowalski, R. J.; Hamel, E.; Lin, C. M.; Longley, R. E.; Gunasekera, S. P.; Rosenkranz, H. S.; Day, B. W. Discodermolide, a Cytotoxic Marine Agent that Stabilizes Microtubules More Potently than Taxol. Biochemistry 1996, 35, 243-250.
53. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
54. Williams, R. C., Jr.; Lee, J. C. Preparation of tubulin from Brain. Methods Enzymol. 1982, 85, 376-385.
55. Swindell, C. S.; Krauss, N. E.; Horwitz, S. B.; Ringel, I. Biologically Active Taxol Analogues with Deleted A-Ring Side Chain Substituents and Variable C-2′ Configurations. J. Med. Chem. 1991, 34, 1176-1184.